home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Pirate Protein Allows Infection Of Resting Cells

 
  July, 14 2003 8:13
your information resource in human molecular genetics
 
     
Even after intense anti-viral treatment, HIV-1 can still lurk in inactive cells in the human body, only to reappear at a later date. New research in this week's Nature (Vol. 424, No. 6945, dated 10 July 2003, pp. 213-219) shows how viruses can create these reservoirs and infect inactive T cells.

Three cell types are involved in the process, according to Mario Stevenson and colleagues. First of all, HIV-1 infects a macrophage, causing it to produce a key viral protein, called Nef. The macrophage then releases at least two soluble factors, which stimulate another component of the immune system - nearby B cells. When these cells come into contact with non-cell-cycling T cells, the T cells become susceptible to HIV-1 infection.

"Nef is a key viral protein in disease induction in vivo by both HIV-1 and SIV, acting in the pathway that induces changes in the activation of an infected cell," says Roger J. Pomerantz in an accompanying News and Views article. "So Nef seems to engage in molecular piracy, taking over an existing cellular pathway and allowing HIV-1 to replicate in T cells in diverse activation states," he adds.

CONTACT:

Mario Stevenson
(University of Massachusetts Medical School, Worcester, MA, USA)
Tel: +1 508 856 4582
E-mail: mario.stevenson@umassmed.edu

Roger J. Pomerantz
(Thomas Jefferson University, Philadelphia, PA, USA)
Tel: +1 215 503 8575
E-mail: roger.j.pomerantz@mail.tju.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.